Current Status of Sarcopenia in Korea: A Focus on Korean Geripausal Women

Overview

Journal Ann Geriatr Med Res

Specialty Geriatrics

Date 2020 Aug 4

PMID 32743248

Citations 14

Authors

Hyoung Moo Park

Affiliations

Soon will be listed here.

Abstract

Sarcopenia is defined as an age-associated decline in muscle mass and function caused by several etiologies and mechanisms. Muscle mass and function do not decrease concurrently, and a loss of muscle function may be more highly associated with adverse health outcomes. Despite the clinical significance of sarcopenia, no universally operational definition of sarcopenia or standardized intervention programs are currently available. Sarcopenia, osteoporosis, and obesity share several pathophysiological mechanisms, and a combination of these entities may lead to an increased risk of musculoskeletal, cardio-metabolic, and psychological morbidities especially in geripause populations. Treatment for sarcopenia is mainly nonpharmacological, however, various drugs are currently being developed. It is conceivable that sarcopenia is the next immediate clinical target in musculoskeletal science.

Citing Articles

Relationship Between Lifestyle and Physical Fitness Among Older Women with Sarcopenia.

Sung J, Lee M, Kim J Int J Mol Sci. 2025; 26(5).

PMID: 40076821 PMC: 11900403. DOI: 10.3390/ijms26052205.

Effect of Chair-stand Exercise on Improving Urinary and Defecation Independence in Post-stroke Rehabilitation Patients with Sarcopenia.

Kido Y, Yoshimura Y, Wakabayashi H, Nagano F, Bise T, Matsumoto A Prog Rehabil Med. 2024; 9:20240029.

PMID: 39280961 PMC: 11393472. DOI: 10.2490/prm.20240029.

Association between Dynapenia and Multimorbidity in Community-Dwelling Older Adults: A Systematic Review.

Ohinata H, Yun S, Miyajima N, Yuki M Ann Geriatr Med Res. 2024; 28(3):238-246.

PMID: 38724450 PMC: 11467507. DOI: 10.4235/agmr.24.0007.

Association of Handgrip Strength and Cardiovascular Disease Risk Among Middle-Aged Postmenopausal Women: An Analysis of the Korea National Health and Nutrition Examination Survey 2014-2019.

Park J, Park S Vasc Health Risk Manag. 2024; 20:183-194.

PMID: 38628618 PMC: 11020303. DOI: 10.2147/VHRM.S442277.

Factors influencing health-related quality of life in older adult women with sarcopenia: analysis of the Korean National Health and Nutrition Examination Survey 2019.

Lee S, Nho J, Kim H, Lee E Korean J Women Health Nurs. 2024; 29(4):328-336.

PMID: 38204392 PMC: 10788388. DOI: 10.4069/kjwhn.2023.12.14.

References

Kim Y, Lee Y, Chung Y, Lee D, Joo N, Hong D . Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012; 67(10):1107-13. DOI: 10.1093/gerona/gls071. View

Paddon-Jones D, Rasmussen B . Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care. 2008; 12(1):86-90. PMC: 2760315. DOI: 10.1097/MCO.0b013e32831cef8b. View

Steffl M, Bohannon R, Sontakova L, Tufano J, Shiells K, Holmerova I . Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017; 12:835-845. PMC: 5441519. DOI: 10.2147/CIA.S132940. View

Lynch J, Henderson N, Ramage L, McMurdo M, Witham M . Association between statin medication use and improved outcomes during inpatient rehabilitation in older people. Age Ageing. 2011; 41(2):260-2. DOI: 10.1093/ageing/afr159. View

Kim T, Yang S, Yoo H, Lim K, Kang H, Song W . Prevalence of sarcopenia and sarcopenic obesity in Korean adults: the Korean sarcopenic obesity study. Int J Obes (Lond). 2009; 33(8):885-92. DOI: 10.1038/ijo.2009.130. View

Cruz-Jentoft A, Landi F, Schneider S, Zuniga C, Arai H, Boirie Y . Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43(6):748-59. PMC: 4204661. DOI: 10.1093/ageing/afu115. View

Miljkovic N, Lim J, Miljkovic I, Frontera W . Aging of skeletal muscle fibers. Ann Rehabil Med. 2015; 39(2):155-62. PMC: 4414960. DOI: 10.5535/arm.2015.39.2.155. View

Rizzoli R, Boonen S, Brandi M, Bruyere O, Cooper C, Kanis J . Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 2013; 29(4):305-13. DOI: 10.1185/03007995.2013.766162. View

Renganathan M, Messi M, Delbono O . Dihydropyridine receptor-ryanodine receptor uncoupling in aged skeletal muscle. J Membr Biol. 1997; 157(3):247-53. DOI: 10.1007/s002329900233. View

10.

Symons T, Schutzler S, Cocke T, Chinkes D, Wolfe R, Paddon-Jones D . Aging does not impair the anabolic response to a protein-rich meal. Am J Clin Nutr. 2007; 86(2):451-6. DOI: 10.1093/ajcn/86.2.451. View

11.

Kwon H, Ha Y, Park H . The Reference Value of Skeletal Muscle Mass Index for Defining the Sarcopenia of Women in Korea. J Bone Metab. 2015; 22(2):71-5. PMC: 4466447. DOI: 10.11005/jbm.2015.22.2.71. View

12.

Binkley N, Krueger D, Buehring B . What's in a name revisited: should osteoporosis and sarcopenia be considered components of "dysmobility syndrome?". Osteoporos Int. 2013; 24(12):2955-9. DOI: 10.1007/s00198-013-2427-1. View

13.

Kim M, Morley J . The hormonal fountains of youth: myth or reality?. J Endocrinol Invest. 2006; 28(11 Suppl Proceedings):5-14. View

14.

Ilich J, Kelly O, Inglis J, Panton L, Duque G, Ormsbee M . Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev. 2014; 15:51-60. DOI: 10.1016/j.arr.2014.02.007. View

15.

Sjoblom S, Suuronen J, Rikkonen T, Honkanen R, Kroger H, Sirola J . Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia. Maturitas. 2013; 75(2):175-80. DOI: 10.1016/j.maturitas.2013.03.016. View

16.

Takayama K, Katakami N, Yokoyama T, Atagi S, Yoshimori K, Kagamu H . Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial. Support Care Cancer. 2016; 24(8):3495-505. PMC: 4917578. DOI: 10.1007/s00520-016-3144-z. View

17.

Kung T, Szabo T, Springer J, Doehner W, Anker S, von Haehling S . Cachexia in heart disease: highlights from the ESC 2010. J Cachexia Sarcopenia Muscle. 2011; 2(1):63-69. PMC: 3063868. DOI: 10.1007/s13539-011-0020-z. View

18.

Ruiz Garcia V, Lopez-Briz E, Carbonell Sanchis R, Gonzalvez Perales J, Bort-Marti S . Megestrol acetate for treatment of anorexia-cachexia syndrome. Cochrane Database Syst Rev. 2013; (3):CD004310. PMC: 6418472. DOI: 10.1002/14651858.CD004310.pub3. View

19.

Adunsky A, Chandler J, Heyden N, Lutkiewicz J, Scott B, Berd Y . MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Arch Gerontol Geriatr. 2010; 53(2):183-9. DOI: 10.1016/j.archger.2010.10.004. View

20.

Holecek M . Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions. J Cachexia Sarcopenia Muscle. 2017; 8(4):529-541. PMC: 5566641. DOI: 10.1002/jcsm.12208. View